EPT Fumarate: A Novel Therapeutic Agent for Mitochondrial Dysfunction
Mitochondrial dysfunction is a major contributor to a wide range of degenerative diseases. This deficiency in mitochondrial function can lead to cellular damage, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising approach for addressing this debilitating issue. EPT Fumarate operates by